Scholars World Heart Congress

Posts

Heart disease progress is slowing or stalling, study says. Obesity is likely to blame.

- August 31, 2019

Progress in reducing the number of deaths related to cardiovascular disease has been waning in recent years, heightening concerns that the obesity epidemic in the United States is undoing improvements in heart health. A research letter published Tuesday in Journal of the American Medical Association confirms that although the death rates from heart disease, diabetes, stroke and related disorders have been decreasing for decades, the rates have recently slowed or stalled. “At best, progress has slowed to a halt, and, at worst, our rates of cardiovascular disease are going up,” said Steven Nissen, chief academic officer for the Heart and Vascular Institute at Cleveland Clinic. “And the cause, pretty much everybody agrees, is the obesity epidemic and all of its downstream consequences.” More than 93 million adults and nearly 14 million children and adolescents in the United States are considered to be obese — a number that has been climbing for decades, according

The Truth About Dealing With Heart Failure

- August 26, 2019

A guide to reducing risks and living well even if you develop the condition Congestive heart failure is a serious illness. But it does not, as is sometimes thought, mean the heart stops altogether. It signifies that the muscle is damaged and can no longer pump enough blood to meet the body’s needs. This condition, which affects 1 in 5 adults—usually in the later years—can shorten life. But with proper treatment, people are living longer and better with heart failure. “We have more medications at our disposal today to improve quality of life for people with a weakened heart,” says Guy L. Mintz, M.D., director of cardiovascular health and lipidology at Sandra Atlas Bass Heart Hospital in Manhasset, N.Y. Here’s what to do. Coronary artery disease and heart attacks are major causes of heart failure, says cardiologist Tamara Horwich, M.D., medical director of UCLA’s cardiac rehabilitation program in Los Angeles. Managing your risk for problems—such as high blood pressure, h

Daily ‘polypill’ cuts risk of heart disease by up to 40%

- August 23, 2019

A polypill combining four cheap cardiovascular medicines substantially reduces the risk of serious heart disease, the concept’s first large clinical trial has shown. An international team led by Tehran University of Medical Sciences in collaboration with the University of Birmingham in the UK followed 6,840 middle-aged people in north-eastern Iran over five years. Half took a daily polypill and the rest received only healthy lifestyle advice. The findings, published in The Lancet, showed 201 major cardiovascular events, notably heart attack, stroke and heart failure, among those who took the polypill and 310 in the non-using control group. Taking polypills cut the risk of such cardiovascular events by 40 per cent in people with no history of heart disease and by 20 per cent in those with previous symptoms. “The idea of the polypill has always been appealing, and now we know that a fixed-dose polypill can achieve clinical benefits in practice,” said Professor Reza Malekzadeh, proje

Guideline-Directed Care in Heart Failure Must Target Optimal Dosing

- August 22, 2019

Robert J. DiDomenico, PharmD, FCCP, FHFSA, FACC, who is Associate Professor, Cardiovascular Clinical Pharmacist at the University of Illinois at Chicago College of Pharmacy, brought the 2019 Directions in Pharmacy conference to a close. He discussed improving transitions of care for patients who have heart failure, with an emphasis on the pharmacist’s role. This topic is timely because 6.2 million adults in the United States are currently diagnosed with heart failure. Experts estimate that by 2030, heart failure’s prevalence will increase by 46%. Among adults aged 45 to 95 years, the lifetime risk is 20% to 45%. In the United States, heart failure and its associated transitions of care are significant problems. Most importantly, 30% of patients who are diagnosed with heart failure will die within 1 year and approximately 50% will die within 5 years. This condition accounts for approximately 900,000 hospitalizations annually. Among Medicare beneficiaries, the 30-day hospital r

Scholars World Heart Conference @ Tokyo, Japan

- August 12, 2019

Scholars World Heart Summit THEME: "Enlightening the Advancements and Exploring the New Horizons in Heart Care" November 18-19, 2019 | Tokyo, Japan PS: https://scholarsconferences.com/heartcongress/ Heart Congress aims to advance continuous medical education and encourage a nourishing exchange of facts and ideas about a healthy heart and ways to keep it healthy throughout the lifetime. This will be the best chance to impact the biggest convention of members from the Cardiology department. This Cardiologists Meet will see as mixture of expert Cardiologists , Cardiac Surgeons, Interventional Cardiologists, Scientists, Researchers, Professors, Nurses, Educators, Healthcare Professionals, Physicians, Surgeons, Pharmacists, Students, Research Scholars and other Drug Manufacturing Medical Devices Companies along with various entrepreneurs and exhibitors. The Organizing Committee of Heart Congress cordially invites all the people who are interested in t

HIV Infection Increases Risk for Cardiovascular Disease and Stroke

- July 18, 2019

Patients with HIV have an increased risk for cardiovascular disease (CVD), in particular, a high risk for heart failure (HF ) and stroke, according to results published in the Journal of the American Heart Association . The study included participants with HIV (n=19,798) and age- and sex-matched controls without HIV (n=59,302) from the MarketScan Commercial and Medicare databases from 2009 to 2015. The researchers used validated algorithms to identify incidence of CVDs , including myocardial infarction (MI), HF, atrial fibrillation (AF), peripheral artery disease, stroke, and CVD-related hospitalization. They used adjusted Cox models to estimate hazard ratios (HRs) and 95% CIs of CVD endpoints. After a mean follow-up of 20 months, the researchers identified 154 MIs (46 among participants with HIV and 108 among controls), 223 cases of HF (116 among participants with HIV and 107 among controls), 93 strokes (46 among participants with HIV and 47 among controls), 397 cases of AF (

Smoking triples risk of death from heart disease and stroke: Study

- July 04, 2019

Smoking is killing 17 Australians a day from stroke, heart attack, and other cardiovascular conditions, according to a large-scale Australian study. ‘A population almost twice the size of Port Douglas is being wiped out in Australia each year, with smoking causing more than 6400 cardiovascular deaths, including from heart attack and stroke.’ That is Professor Emily Banks from the ANU National Centre for Epidemiology and Population Health, lead author of the world-first study. Published in BMC medicine , the study utilised health information from 188,167 cardiovascular disease (CVD) and cancer-free people who joined the Sax Institute’s 45 and Up Study. They were monitored for up to 36 different types of CVD over seven years, making the study the first research to trace the effects of smoking on the entire cardiovascular system. ‘That includes investigating the risk of heart attack, stroke, heart failure, heart muscle disease, rhythm problems, and gangrene in

Coronary heart disease may speed up cognitive decline

- June 21, 2019

It is natural for a person's memory and thinking abilities, or cognitive function, to wane as they age — even if they are in good health. However, the rate of cognitive decline can speed up if they experience heart attack or angina, according to new research. Studies that have explored the links between circulation problems and cognitive decline have tended to focus on conditions that affect the blood supply to the brain, such as stroke . Few of these earlier studies, however, have looked at the long-term links between incident coronary heart disease (CHD), such as heart attack and angina, and cognitive decline. The recent Journal of the American College of Cardiology study is unique; it tracked cognitive decline both before and after incident CHD. "Incident CHD," its authors conclude, "is associated with accelerated cognitive decline after, but not before, the event." They suggest that the findings highlight the long-term relationship betwee

Heart attack: The test which could reveal if you are having a heart attack

- June 17, 2019

A HEART attack happens when there is a sudden loss of blood flow to part of the heart muscle. Most heart attacks happen when the inside of one or more of the coronary arteries becomes narrowed due to the gradual build up of fatty deposits known as atheroma. In the UK there are more than 100,000 hospital admissions each year due to heart attacks. Could a simple blood test help doctors predict the risk of heart attacks in people? If a piece of fatty material breaks off, a blood clot could form which tries to repair the damage to the artery wall. The blood clot could block the coronary artery, causing part of the heart muscle to be starved of blood and oxygen and this is when a heart attack occurs. An incredible 1.4 million people alive in the UK today have survived a heart attack. Death rates from coronary heart disease are the highest in areas of great deprivation and 42,000 people died prematurely from cardiovascular disease. New research suggest that by detecting the